The latest price target for Oscar Health (NYSE:OSCR) was reported by B of A Securities on November 6, 2024. The analyst firm set a price target for $13.50 expecting OSCR to fall to within 12 months (a possible -18.33% downside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Oscar Health (NYSE:OSCR) was provided by B of A Securities, and Oscar Health downgraded their underperform rating.

The last upgrade for Oscar Health Inc happened on November 2, 2023 when B of A Securities raised their price target to $9. B of A Securities previously had a neutral for Oscar Health Inc.

The last downgrade for Oscar Health Inc happened on November 6, 2024 when B of A Securities changed their price target from $21 to $13.5 for Oscar Health Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oscar Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oscar Health was filed on November 6, 2024 so you should expect the next rating to be made available sometime around November 6, 2025.

While ratings are subjective and will change, the latest Oscar Health (OSCR) rating was a downgraded with a price target of $21.00 to $13.50. The current price Oscar Health (OSCR) is trading at is $16.53, which is out of the analyst’s predicted range.